Wei Shi
Affiliations: | University of Arkansas, Little Rock, AR |
Google:
"Wei Shi"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Shi W, Xu G, Gao Y, et al. (2024) Compound Danshen Dripping Pill effectively alleviates cGAS-STING-triggered diseases by disrupting STING-TBK1 interaction. Phytomedicine : International Journal of Phytotherapy and Phytopharmacology. 128: 155404 |
| Zhou J, Xie Z, Wang J, et al. (2023) Design, synthesis and bioactivity evaluation of novel fusion peptides and their CPT conjugates inducing effective anti-tumor responses on HER2 positive tumors. European Journal of Medicinal Chemistry. 264: 116032 |
| Tao S, Yang EJ, Zong G, et al. (2023) ER translocon inhibitor ipomoeassin F inhibits triple-negative breast cancer growth via blocking ER molecular chaperones. International Journal of Biological Sciences. 19: 4020-4035 |
| Harris TJ, Liao Y, Shi W, et al. (2023) Induction of endoplasmic reticulum stress is associated with the anti-tumor activity of monepantel across cancer types. Cancer Medicine |
| Qiu Q, Chi F, Zhou D, et al. (2023) Exploration of Janus Kinase (JAK) and Histone Deacetylase (HDAC) Bispecific Inhibitors Based on the Moiety of Fedratinib for Treatment of Both Hematologic Malignancies and Solid Cancers. Journal of Medicinal Chemistry |
| Liu F, Wang B, Liu Y, et al. (2023) Design, synthesis and biological evaluation of novel N-(methyl-d) pyridazine-3-carboxamide derivatives as TYK2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 86: 129235 |
| Ren J, Gao Y, Shi W, et al. (2022) Design and synthesis of boron-containing ALK inhibitor with favorable in vivo efficacy. Bioorganic & Medicinal Chemistry. 75: 117071 |
| Li H, Wang Y, Lin K, et al. (2022) CHD1 promotes sensitivity to Aurora kinase inhibitors by suppressing interaction of AURKA with its coactivator TPX2. Cancer Research |
| Wang Q, Hu X, Shi W, et al. (2022) Design, synthesis and biological evaluation of chromone derivatives as novel protein kinase CK2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 69: 128799 |
| Shi W, Feng Z, Chi F, et al. (2022) Structure-based discovery of receptor tyrosine kinase AXL degraders with excellent anti-tumor activity by selectively degrading AXL and inducing methuosis. European Journal of Medicinal Chemistry. 234: 114253 |